ATE350064T1 - Pharmazeutische zusammensetzungen von rapamycines - Google Patents
Pharmazeutische zusammensetzungen von rapamycinesInfo
- Publication number
- ATE350064T1 ATE350064T1 AT02735219T AT02735219T ATE350064T1 AT E350064 T1 ATE350064 T1 AT E350064T1 AT 02735219 T AT02735219 T AT 02735219T AT 02735219 T AT02735219 T AT 02735219T AT E350064 T1 ATE350064 T1 AT E350064T1
- Authority
- AT
- Austria
- Prior art keywords
- pharmaceutical compositions
- rapamycines
- ascomycin
- prevention
- reduction
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- ZDQSOHOQTUFQEM-PKUCKEGBSA-N ascomycin Chemical compound C/C([C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H]([C@H](C[C@H]2C)OC)[C@@H](OC)C[C@@H](C)C\C(C)=C/[C@H](C(C[C@H](O)[C@H]1C)=O)CC)=C\[C@@H]1CC[C@@H](O)[C@H](OC)C1 ZDQSOHOQTUFQEM-PKUCKEGBSA-N 0.000 abstract 1
- ZDQSOHOQTUFQEM-XCXYXIJFSA-N ascomycin Natural products CC[C@H]1C=C(C)C[C@@H](C)C[C@@H](OC)[C@H]2O[C@@](O)([C@@H](C)C[C@H]2OC)C(=O)C(=O)N3CCCC[C@@H]3C(=O)O[C@H]([C@H](C)[C@@H](O)CC1=O)C(=C[C@@H]4CC[C@@H](O)[C@H](C4)OC)C ZDQSOHOQTUFQEM-XCXYXIJFSA-N 0.000 abstract 1
- 229920002678 cellulose Polymers 0.000 abstract 1
- 239000001913 cellulose Substances 0.000 abstract 1
- 239000013078 crystal Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0108498.7A GB0108498D0 (en) | 2001-04-04 | 2001-04-04 | Organic Compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE350064T1 true ATE350064T1 (de) | 2007-01-15 |
Family
ID=9912264
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02735219T ATE350064T1 (de) | 2001-04-04 | 2002-04-03 | Pharmazeutische zusammensetzungen von rapamycines |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US20040171599A1 (de) |
| EP (1) | EP1377315B1 (de) |
| JP (1) | JP4927310B2 (de) |
| CN (2) | CN100358580C (de) |
| AT (1) | ATE350064T1 (de) |
| AU (1) | AU2002310920A1 (de) |
| BR (1) | BR0208655A (de) |
| CA (1) | CA2443235C (de) |
| DE (1) | DE60217315T2 (de) |
| GB (1) | GB0108498D0 (de) |
| PT (1) | PT1377315E (de) |
| WO (1) | WO2002080978A2 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004071398A2 (en) * | 2003-02-17 | 2004-08-26 | Cipla Ltd | Pharmaceutical patch |
| US20040185093A1 (en) * | 2003-03-18 | 2004-09-23 | Szymczak Christopher E. | Compositions containing sucralose |
| PT1734927E (pt) * | 2004-04-08 | 2012-09-05 | Meda Pharma S A R L | Composição em espuma de pimecrolimus contendo hexilenoglicol, opcionalmente álcool oleílico, dimetilisossorbida e/ou triglicéridos de cadeia média |
| US20060062811A1 (en) * | 2004-09-21 | 2006-03-23 | Szymczak Christopher E | Medicinal cooling emulsions |
| GB0508827D0 (en) * | 2005-04-29 | 2005-06-08 | Novartis Ag | Cosmeceutical composition |
| KR101462474B1 (ko) * | 2013-10-30 | 2014-11-19 | 주식회사 큐리언트 | 질레우톤 크림 제형의 국소용 항염증 약학적 조성물 |
| US9855243B2 (en) | 2013-10-30 | 2018-01-02 | Qurient Co., Ltd. | Topical anti-inflammatory pharmaceutical composition with zileuton cream formulation |
| CA2985080A1 (en) * | 2015-05-08 | 2016-11-17 | Vivus, Inc. | Compositions and methods for the treatment or prevention of pulmonary hypertension |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4127647A (en) * | 1975-04-08 | 1978-11-28 | Meiji Seika Kaisha, Ltd. | Process for preparation of stable amorphous macrolide antibiotic solids |
| GB8608080D0 (en) * | 1986-04-02 | 1986-05-08 | Fujisawa Pharmaceutical Co | Solid dispersion composition |
| DK0406791T3 (da) * | 1989-07-05 | 1995-03-27 | Fujisawa Pharmaceutical Co | Vandigt flydende præparat til ekstern anvendelse |
| PH31204A (en) * | 1990-11-02 | 1998-05-05 | Fujisawa Pharmaceutical Co | Pharmaceutical composition. |
| IE65341B1 (en) * | 1990-11-08 | 1995-10-18 | Fujisawa Pharmaceutical Co | Suspensions containing tricyclic compounds |
| PT786986E (pt) * | 1994-10-26 | 2002-07-31 | Novartis Ag | Formulacoes farmaceuticas |
| ATE269075T1 (de) * | 1998-03-26 | 2004-07-15 | Fujisawa Pharmaceutical Co | Makrolid-formulierung mit verzögerter wirkstoffabgabe |
| ES2284248T3 (es) * | 1998-04-27 | 2007-11-01 | Astellas Pharma Inc. | Formulacion farmaceutica en gel que comprende un compuesto triciclico (fk-506/tacrolimus). |
| GB9817064D0 (en) * | 1998-08-05 | 1998-10-07 | Fujisawa Pharmaceutical Co | New use |
| AUPR529701A0 (en) * | 2001-05-28 | 2001-06-21 | Fujisawa Pharmaceutical Co., Ltd. | Pharmaceutical composition |
-
2001
- 2001-04-04 GB GBGB0108498.7A patent/GB0108498D0/en not_active Ceased
-
2002
- 2002-04-03 AU AU2002310920A patent/AU2002310920A1/en not_active Abandoned
- 2002-04-03 CN CNB2005100555523A patent/CN100358580C/zh not_active Expired - Fee Related
- 2002-04-03 WO PCT/EP2002/003694 patent/WO2002080978A2/en not_active Ceased
- 2002-04-03 PT PT02735219T patent/PT1377315E/pt unknown
- 2002-04-03 BR BR0208655-7A patent/BR0208655A/pt not_active IP Right Cessation
- 2002-04-03 AT AT02735219T patent/ATE350064T1/de active
- 2002-04-03 US US10/473,782 patent/US20040171599A1/en not_active Abandoned
- 2002-04-03 DE DE60217315T patent/DE60217315T2/de not_active Expired - Lifetime
- 2002-04-03 CA CA2443235A patent/CA2443235C/en not_active Expired - Fee Related
- 2002-04-03 JP JP2002579016A patent/JP4927310B2/ja not_active Expired - Fee Related
- 2002-04-03 CN CNB028079108A patent/CN1226047C/zh not_active Expired - Fee Related
- 2002-04-03 EP EP02735219A patent/EP1377315B1/de not_active Expired - Lifetime
-
2007
- 2007-07-24 US US11/880,803 patent/US20070298058A1/en not_active Abandoned
-
2011
- 2011-05-23 US US13/113,331 patent/US20110224246A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP4927310B2 (ja) | 2012-05-09 |
| AU2002310920A1 (en) | 2002-10-21 |
| CA2443235C (en) | 2011-03-15 |
| BR0208655A (pt) | 2004-03-02 |
| EP1377315B1 (de) | 2007-01-03 |
| PT1377315E (pt) | 2007-02-28 |
| HK1061647A1 (en) | 2004-09-30 |
| CN100358580C (zh) | 2008-01-02 |
| DE60217315T2 (de) | 2007-05-31 |
| WO2002080978A2 (en) | 2002-10-17 |
| EP1377315A2 (de) | 2004-01-07 |
| WO2002080978A3 (en) | 2003-10-30 |
| US20070298058A1 (en) | 2007-12-27 |
| CN1226047C (zh) | 2005-11-09 |
| DE60217315D1 (de) | 2007-02-15 |
| US20040171599A1 (en) | 2004-09-02 |
| US20110224246A1 (en) | 2011-09-15 |
| GB0108498D0 (en) | 2001-05-23 |
| CN1501814A (zh) | 2004-06-02 |
| JP2004525169A (ja) | 2004-08-19 |
| CN1679962A (zh) | 2005-10-12 |
| CA2443235A1 (en) | 2002-10-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR200103493T2 (tr) | Metaloproteaz önleyicileri | |
| CY1108532T1 (el) | Ενωσεις και συνθεσεις για την παροχη δραστικων παραγοντων | |
| DE60038183D1 (de) | Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe | |
| ATE464049T1 (de) | Pharmazeutische kombinationen von hydrocodon und naltrexon | |
| ATE376832T1 (de) | Verzögert freisetzende formulierungen von oxymorphon | |
| WO2004030611A3 (en) | Non-nucleoside reverse transcriptase inhibitors | |
| HUP0202570A1 (hu) | Izoflavonokat és analogonjait tartalmazó készítmények és terápiás alkalmazásuk | |
| ATE402176T1 (de) | Pyrrolidin- und azetidinverbindungen alsccr5- antagonisten | |
| BR0314797A (pt) | Derivados da pirimidineamida e o uso dos mesmos | |
| CY1110664T1 (el) | Ενδορινικες συνθεσετς | |
| SE0101932D0 (sv) | Pharmaceutical combinations | |
| ATE495187T1 (de) | Dalda-analoge und ihre verwendung | |
| BRPI0410049A (pt) | composto ou um sal ou estereoisÈmero farmaceuticamente aceitável do mesmo, uso de um composto, composição farmacêutica, e, kit farmacêutico | |
| DK1187803T3 (da) | Amorfe salpetersyreestere og deres farmaceutiske sammensætninger | |
| MXPA03010054A (es) | Composiciones que comprenden lopinavir y metodos para aumentar la biodisponibilidad de agentes farmaceuticos. | |
| ATE319473T1 (de) | Melagatran zur behandlung von entzündungen | |
| DE60217315D1 (de) | Pharmazeutische zusammensetzungen von rapamycines | |
| IL153540A0 (en) | THE USE OF 7beta-HYDROXY-STEROID DERIVATIVES FOR THE MANUFACTURE OF PHARMACEUTICAL COMPOSITIONS | |
| EE05241B1 (et) | Distamtsiini a-halogenoakrlolderivaadi kasutamine | |
| BG102661A (en) | Benzo/o/quinolysine derivatives, their preparation and application as 5a-reductase inhibitors | |
| AU2001252419A1 (en) | Thrombin inhibitors | |
| ES2192789T3 (es) | Derivados de hidrazono-benzazuleno, composiciones farmaceuticas y compuestos intermedios. | |
| DK1181300T3 (da) | 6-O-carbamatketolidderivater | |
| MXPA05007253A (es) | Sales novedosas de derivados anticonvulsivantes. | |
| MXPA01009032A (es) | Composicion farmaceutica para la prevencion o el tratamiento de una enfermedad asociada con un exceso se la produccion de il-12. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1377315 Country of ref document: EP |